Learn more
Log in
0 followers
Facile Therapeutics is bringing Ebselen into the clinic to demonstrate it will be effective in preventing the recurrence of CDI in a Proof-of-Concept (PoC) clinical trial.
Industries
Headquarters
Stage
Employees
Links
Marc Navre
8 members
3 members
Thermo Fisher Scientific
126 followers
Genentech
134 followers
Biogen
99 followers
Alexion Pharmaceuticals
27 followers
BioMarin Pharmaceutical
25 followers
Discover companies